Maria Gonzalez-Carmona

19PUBLICATIONS
87CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionPredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 09, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.

Racha Hosni, Niklas Klümper, Christine Sanders

|Jun 13, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.

Racha Hosni, Niklas Klümper, Christine Sanders

|Mar 28, 2025
Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study.

Christian Möhring, Moritz Berger, Farsaneh Sadeghlar

|Jan 08, 2025
Longitudinal Study of SARS-CoV-2 Vaccinations and Infections in Patients with Gastrointestinal Cancer: Stabilizing Immune Responses and Neutralizing Emerging Variants with Variant-Adapted Antigen Exposures.

Maria A Gonzalez-Carmona, Alina M Schmitz, Moritz Berger

|Nov 04, 2024
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort.

Tiago de Castro, Sabrina Welland, Leonie Jochheim

|Jul 13, 2024
Study Protocol of a Randomized, Two-Arm, Phase I/II Trial Investigating the Feasibility, Safety, and Efficacy of Local Treatment with US-Guided High-Intensity Focused Ultrasound in Combination with Palliative Chemotherapy in Inoperable Pancreatic Cancer.

Milka Marinova, David-Alexis Khouri, Jim Küppers

Pageof 4

Frequent Collaborators

5 joint publications

Ingo G H Schmidt-Wolf

4 joint publications

Vittorio Branchi

4 joint publications

Ingo G H Schmidt-Wolf

3 joint publications

Christian Möhring